http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2464648-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f8cc73a5d5af1e5a2f1ea7c53dd8a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_937963b39574534b8499d23588e27a2e |
publicationDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2464648-A1 |
titleOfInvention | Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazine |
abstract | The present invention relates to a crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine (INN:Sitagliptin) of the formula (1), having fumaric acid or a hydrate thereof, wherein the molar ratio of the compound of the formula (1) to fumaric acid is 1:0.6 to 1:1.3, and a method for the production thereof. |
priorityDate | 2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.